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According to current estimates, Plasmodium malariae is not very common in Senegal, as more than 98% of malaria
cases are suspected to be due to Plasmodium falciparum. However, it is possible that other malarial species are
being under-reported or misdiagnosed. This is a report of a case of P. malariae in a 30-year-old man previously
hospitalized with acute kidney injury after treatment with quinine and re-hospitalized three months later. He was
diagnosed with renal cortical necrosis post malaria treatment. Plasmodium malariae was identified with light
microscope and confirmed using species-specific small-subunit rRNA (ssrRNA) amplification.
The patient was treated for malaria with intravenous quinine for seven days, followed by three days of oral
treatment; the bacterial infection was treated using ceftriaxone during the first hospitalization and ciprofloxacin
associated with ceftriaxone the second time. He also had four rounds of dialysis after which he partially recovered
the renal function. Given the complications that can be caused by P. malariae infection, it should be systematically
looked for, even if the predominant species is P. falciparum in Senegal.
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Senegal is a malaria endemic region with a predominance
of Plasmodium falciparum. Over the few last years, the ma-
laria burden in Senegal has declined but the disease remains
endemic. Other species such as Plasmodium malariae, and
Plasmodium ovale are present in Senegal, but recent data
on their frequencies is lacking. Although, infections with
non-falciparum species generally result in mild disease
[1,2], their identification is important. In fact, P. malariae is
known not to cause severe symptoms, but is sometimes
associated with renal pathology [3-6]. Evidence suggests that
P. malariae does not cause relapse, but low level para-
sitaemia can persist for years and recrudescent infections
are well documented [7] and can cause disease years after
the initial infection [8]. As falciparum malaria can cause
severe and fatal disease, significant research has focused on* Correspondence: asbadiane@gmail.com
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buted to less research focus on the other human malarias
and their disease burden being underestimated. This is a
report of a case of P. malariae diagnosed in a patient
living in Dakar and previously hospitalized with acute
kidney injury.Case presentation
A 30-year-old man first presented at a health centre in
Dakar, Senegal (Abdoul Aziz Sy health care Centre) with
fever, headaches, myalgia, and vomiting. He was hospi-
talized and treated for malaria with quinine, based on
clinical diagnosis although malaria diagnosis was not
confirmed by biological test. The patient failed to re-
cover and he was referred to the Infectious Disease
Clinic (Fann Hospital, Dakar, a national reference hospital)
where he was treated with furosemide, metronidazole,
metopimazine, dycinone and omeprazole, he presented
with anuria for three days. He was negative for malaria by
microscopy at Fann Hospital. He was transferred to the
Nephrology Clinic (Aristide LeDantec Hospital, a national
reference hospital) with creatinine of 152.52 mg/L andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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dialysis at Aristide LeDantec Hospital, where the molecu-
lar diagnostic unit is located.
The patient presented fever, anaemia, ascitis of low
abundance, insomnia and asthenia. He received ceftriax-
one 1 g/day, and the furosemide continued to be adminis-
tered. During the course of hospitalization, he received
four rounds of dialysis and three blood transfusions. Cre-
atinine, urea and potassium were measured to monitor
the renal function during hospitalization (Table 1). At re-
lease his creatinine was 82.69 mg/L and urea was 1.62 g/L
(Table 1).
The patient was hospitalized again three months later in
another health centre (Philippe Senghor health care centre);
suffering from diarrhoea, fever, chills, asthenia and anorexia
for a week. Given his renal condition, he was referred to Ar-
istide LeDantec Hospital again, with creatinine of 67 mg/L
and urea of 2.40 g/L. The potassium was 6.4 mmol/L; there-
fore, a dialysis was performed in emergency. After a month
of treatment the laboratory test results were creatinine,
34.5 mg/L; creatinine clearance, 27.7 ml/min; sodium (Na+),
132 mmol/L; potassium (K+), 5.1 mmol/L; chloride (Cl-),
108 mmol/L; total protein, 71.3 g/L.
He was treated with ceftriaxone 1 g per day and cipro-
floxacin 1 g per day because typhoid was suspected and the
doses were adapted to his renal condition. But a non-
fermentative Gram negative bacillus was isolated from
blood culture and typhoid investigation by Widal test and
stool culture was negative. Malaria diagnosis by microscopy
was performed one week after his admission and was posi-
tive for P. malariae. He was then treated with quinine
500 mg intravenous (1/2 ampoule in 250 mm3 of 10%
serum glucose for 4 hours) during 7 days, then by oral
route for three days and paracetamol intramuscular was ad-
ministered for the pain. Renal biopsy was prescribed and
showed parenchyme fragments with 80% nephrotic reduc-








7/11/12 (Jo) 124.52 2.52 4.7 None
10/11/12 (J3) 5.3 Yes
12/11/12/ (J5) 166.25 3.13 4.7 Yes
15/11/12 (J8) 161.47 2.62 None
20/11/12/ (J13) 217 4.31 None
21/11/12 (J14) Yes
22/11/12 (J15) 100 1.49 None
23/11/12 (J16) 115.55 1.75 None
24/11/12 (J17) Yes
27/11/12 (J20) 87.89 1.89 None
3/12/12 82 1.62 Nonelesions were seen for 30% of residual glomeruli, and an
extended mutilating interstitial fibrosis and atherosclerosis
lesions of variable distribution between severe to moderate
was also noted.
The appearance evoked a subtotal cortical necrosis
probably on severe nephroangiosclerosis lesions and
pyelonephritis was probably associated. The diagnosis of
cortical necrosis post malaria was, therefore, established.
At the end of hospitalization, creatinine was 29.4 mg/L,
urea 0.48 g/L and the glomerular filtration rate (GFR)
30 ml/min, which means the renal function was not fully
recovered and is in agreement with the renal necrosis. The
patient is still being monitored in the nephrology clinic.
Light microscopy results
Thin and thick blood smears were sent to the laboratory
of parasitology at Le Dantec Hospital for malaria diagnosis
by light microscopy. Slides were stained with 10% Giemsa
for 15 minutes. Plasmodium malariae was diagnosed with
a parasite density of 18.402 trophozoites/μl (Figure 1).
Rapid diagnosis test results
To confirm, the microscopy result, we asked for a blood
sample and performed the RDT/HRP2 SD Bioline Malaria
Ag Pf with a (sensitivity of 99.7% for 100 parasites/μl and
a specificity of 99.5%), which is specific to P. falciparum.
The test was negative ruling out P. falciparum infection,
which is more common in Senegal.
Molecular diagnostic testing ssrRNA gene amplification
by polymerase chain reaction (PCR)
To confirm the diagnosis of P. malariae, DNA was ex-
tracted from whole blood with the QIAamp DNA blood
mini kit (Qiagen). The ssrRNA gene was amplified as pre-
viously described [9,10] with minor modifications. First
round PCR to detect Plasmodium genus was performed
using the following primers rPLUf 5’- TTA AAA TTG
TTG CAG TTA AAA CG and rPLUr 5’- CCT GTT GTT
GCC TTA AAC TTC. The second round PCR with
primers specific to 4 Plasmodium species:
P. malariae rMALf5’- ATA ACA TAG TTG TAC GTT
AAG AAT AAC CGC and rMALr AAA ATT CCC ATG
CATAAA AAATTATAC AAA
P. falciparum rFALf 5’- TTA AAC TGG TTT GGG
AAA ACC AAA TATATT and rFALr 5’- ACA CAATGA
ACT CAATCATGA CTA CCC GTC
P. ovale rOVAf 5’- ATC TCT TTT GCT ATT TTT
TAG TAT TGG AGA and rOVAr 5’- GGA AAA GGA
CAC ATTAAT TGTATC CTA GTG
P. vivax rVIVf 5’- CGC TTC TAG CTT AAT CCA
CAT AAC TGA TAC and rVIVr 5’- ACT TCC AAG
CCG AAG CAA AGA AAG TCC TTA
PCR reactions were performed in a final volume of
20 μl: GoTaq (Promega Green Master Mix 2X) 6 μl,
Figure 1 Giemsa-stained thin smear of patient’s peripheral blood. A: Schizont of P. malariae containing merozoites (6 to 12) with large
nuclei and the rosette pattern. B and C: Trophozoites of P. malariae “Basket-form” in a thin smear.
Figure 2 PCR results for Plasmodium species-specific 18S rRNA.
144-bp fragment corresponds to P. malariae was detected from the
PCR-amplified product of thev patient’s blood 205 bp fragment
corresponds to P. falciparum used as a positive control 117 pb
fragment corresponds to P. vivax used as positive control. Ladder:
DNA size marker (100 pb).
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pmol/μl (1 μl), DNA 2 μl, and 10 μl of distilled water.
The PCR programme was as follows: initial denaturation
at 94°C for 4 min, then 35 cycles of 94 for 30 sec, 55°C for
1 min (first round annealing) or 58°C for 1 min (second
round annealing), 72°C for 1 min, final extension at 72°C
for 4 min, and 4°C at the end.
Samples were run on an agarose gel and species deter-
mined based on product size [9]. Plasmodium malariae
was diagnosed at the size band of 144 base pairs (bp)
(Figure 2). Plasmodium falciparum and Plasmodium
vivax strains available in the laboratory, were used as
positive controls.
Discussion
Although P. malariae does not cause life-threatening infec-
tion, it has been associated with kidney injury [11-15],
which is a very serious condition. Unlike P. falciparum,
P. malariae infection is chronic and parasitaemia is often
low which makes microscopic diagnosis difficult. In
Senegal, most rapid diagnosis tests (RDTs) used in public
settings only detect the Histidine Rich Protein 2 (HRP2)
of P. falciparum and PCR is primarily performed for
research purposes. Therefore, patients presenting with
P. malariae can easily misdiagnosed and are often
treated for bacterial infections.
The recommendation of the National Malaria Control
Programme is to combine RDTs with the gold-standard
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RDTs are used, often in rural areas where the expertise
and the equipment for performing microscopy are lacking.
RDTs were developed particularly for use in low resource
settings to facilitate the diagnosis of malaria in the absence
of microscopy. Light microscopy can detect all Plasmo-
dium species but requires extensive training and special-
ized expertise. Different types of RDTs exist and the
choice of RDT implemented depends on the species that
circulate in the area [16]. The most common Plasmodium
species causing clinical malaria in Senegal is P. falciparum,
which represents more than 98% cases. While other
species are present, they are predicted to be at much
lower frequencies. Additionally, co-infections occurring in
P. falciparum endemic areas are often difficult to detect
by microscopy, in a setting of high falciparum parasi-
taemia. The low parasite density of P. malariae compared
to P. falciparum could partially explain why it is under-
diagnosed even by light microscopy [17,18].
Although P. malariae is not known to cause relapse, in-
fected red blood cells can persist for long periods of time
at low densities (<500 parasites/μl). These low densities
are due to the fewer merozoites released after schizont
rupture, increased erythrocytic cycle duration (72 hours
versus 48 hours for P. falciparum), erythrocyte preference
for invasion (mature red blood cells) and the host factors
such as immunity. One study reports P. malariae parasites
isolated from a patient infected 50years earlier while in
China [19].
Although not a common disease in Senegal, P. malariae
can cause public health problems as it is associated with
kidney injury which can be complicated and costly to treat
in low income countries. Given the complications, it is time
to re-evaluate the current diagnostic of choice, in order to
prevent such pathologies associated with P. malariae
infection.Conclusion
For this case the first diagnosis of malaria was only
based on the clinic because biological tests were not
available when the patient came to the hospital. During
his first hospitalization he has been treated for malaria
with quinine, after which he developed kidney injury but
whether quinine or the Plasmodium infection was
responsible of the injury remains unclear because there
is not enough evidence to establish the aetiology.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.Abbreviations
ssrRNA: Small-subunit rRNA; FSGS: Focal segmental glomerulosclerosis;
GFR: Glomerular filtration rate; RDT: Rapid diagnosis test; HRP2: Histidine rich
protein-2; Bp: Base pairs.
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